RT @RichardPAConway: Fleischmann et al. Safety of TYK2i Deucravacitinib in PsA/PsO in terms of labs. Really no effect on
Tweet Content
Fleischmann et al. Safety of TYK2i Deucravacitinib in PsA/PsO in terms of labs. Really no effect on lab values other than increase in trigs. Guess this is why they don't have lab monitoring on label? @RheumNow #ACR22 Abstr#2132 https://t.co/ueIVKQc6jr https://t.co/u99QE71VQ5
Links
Safety of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor: As A…
https://acrabstracts.org/abstract/safety-of-deucravacitinib-an-oral-selective-t…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off